AULSS 2 Marca Trevigiana

National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis

Hannah Blencowe, Julia Krasevec, Mercedes de Onís et al. · The Lancet Global Health · 2019 · 1.1K citations · Full text

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Ian Judson, Jaap Verweij, Hans Gelderblom et al. · The Lancet Oncology · 2014 · 1.1K citations · Full text

Metastatic Soft-tissue Sarcoma, Versus Intensified Doxorubicin, Oncology +7

Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?

Peter B. Lockhart, Ann F. Bolger, Panos N. Papapanou et al. · Circulation · 2012 · 997 citations · Full text

Thrombosis, Periodontology, Vascular Disease +15

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

Kohei Shitara, Florian Lordick, Yung‐Jue Bang et al. · The Lancet · 2023 · 609 citations

Oncology, Esophageal Cancer, Gastrointestinal Oncology +9

Cumulative Incidence Estimation in the Presence of Competing Risks

Vincenzo Coviello, May Boggess · The Stata Journal Promoting communications on statistics and Stata · 2004 · 452 citations · Full text

Engineering, Cumulative Incidence Estimation, Risk Decisions +17